Bharat Biotech has said that a new study shows its indigenously produced Covid-19 vaccine is effective against the coronavirus strains first found in India (B.1.617) and the United Kingdom (B.1.1.7). The company on Sunady claim that Covaxin produces neutralizing titers (concentration) against all the key emerging variants of Covid-19 that were tested. "No difference in neutralization between B.1.1.7 (first found in the UK) and vaccine strain (D614G) was observed," Bharat Biotech said. Suchitra Ella, joint managing director of Bharat Biotech, announced these findings on Twitter.
Covaxin gets international recognition yet again, by scientific research data published demonstrating protection against the new variants.Yet another feather in its cap????????@PMOIndia @nsitharaman @drharshvardhan @MoHFW_INDIA @ICMRDELHI @DBTIndia @doctorsoumya @BharatBiotech pic.twitter.com/AUhphvvivz
— suchitra ella (@SuchitraElla) May 15, 2021
Newsinc24 Team
Related Posts
India not a ‘middle power’ but a power in the middle: EAM Jaishankar
Rajnath Singh calls for stronger India-ASEAN defence cooperation
Vaishnaw says India eyes 25-year roadmap for tech resilience